Sunil Gupta, M.D.

Sunil Gupta, M.D. is a nationally recognized retinal surgeon, a successful entrepreneur, and a healthcare pioneer. He is founder and manager of one of the largest retinal research organizations in the United States, Retina Specialty Institute. His practice serves patients in 16 clinics across the Southeast with 7 physicians.

Dr. Gupta works tirelessly to develop improved healthcare delivery systems built with LEAN methodology and cloud-based technologies. Dr. Gupta and his esteemed colleagues across multiple organizations are on a mission to revolutionize private practice data aggregation, to enhance productivity, and to build efficiency models inspired by Japanese manufacturing. Dr. Gupta thrives on bringing together stakeholders from across the healthcare and business landscape to solve complex challenges and deliver the triple aim of accessible, affordable, and quality patient care.

Dr. Gupta serves on the Retina Advisory Committee for Alcon (RAC2); Executive Committee for LAMPA, Retina Advisory Board for Genentech Pharmaceuticals; and the Retina Advisory Board for Allergan.


Dr. Gupta and Retina Specialty Institute are on the front lines of retina research for new class drugs, leading over 28 clinical trials for conditions such as Macular Degeneration and Diabetic Retinopathy. He assists industry in designing better surgical systems, equipment and processes. Building models of efficiency without sacrificing quality for patients, Dr. Gupta is bringing Six Sigma-inspired systems to healthcare. Additionally, he has developed new medical delivery vehicles, holds multiple diagnostic and pharmaceutical patents, and is leading efforts to bring advanced new synthetic molecules to the forefront of retinal therapy.

His love for patients, whom he respects as equal partners in their care, is reflected in his compassionate, approachable manner. Whereas healthcare delivery can often be perceived as hierarchical in nature, Dr. Gupta believes that physicians today must be able to identify with what the patient is experiencing in order to improve communication and enhance delivery of care.


Dr. Gupta is the co-founder and chief medical officer of USRetina — one of the largest associations of retina physicians in the United States. This rapidly growing association of more than sixty member practices represents over $3 billion in revenue. This young, innovative organization is making bold moves to advance, aggregate, and advocate for the retina vitreous community. USRetina delivers clinical and operational excellence in RetinaVitreous care, benefiting patients, retina physicians, and industry partners. At its heart USRetina strives to put the patients first while preparing its constituent practices for value based medicine.

IRIS: Intelligent Retina Imaging Systems

Dr. Gupta is the founder, chairman and chief medical officer of IRIS: Intelligent Retinal Imaging Systems, an FDA-cleared, cloud based, telemedicine tool for assessment of retinal eye disease in the primary care setting. The award-winning IRIS team is on a mission to end preventable blindness due to Diabetic Retinopathy and other conditions. Using state-of-the art cameras, retinal images are transmitted to a powerful cloud-based platform and evaluated in real-time by remote eye care specialists. IRIS identifies patients at risk, particularly the subset patient group that typically does not seek or have access to care.

IRIS helps to “shoot the gap” in U.S. healthcare, serving as a population health management tool for the countless patients left behind in current delivery models. Additionally, Dr. Gupta has led the development of image enhancement technology to identify sub particle pathology, as well as the automated detection of diabetic retinopathy and glaucoma via advanced algorithms.


Dr. Gupta was the past chairman of the Andrews Institute Ambulatory Surgery Center, and was a key organizer of this joint venture between Baptist Health Care and local physicians. The state-of-the-art surgery center was designed from the ground up to be optimal for outpatient procedures with eight operating rooms featuring the latest technology utilizing high definition camera and video systems.

Dr. Gupta also serves on the board of the Andrews Research & Education Institute, and was instrumental in organizing and helping to obtain funding for its adult stem cell research laboratory.


Dr. Gupta earned his Bachelor of Science degree in chemical engineering from the University of Washington, Seattle, and his Doctor of Medicine degree from the University of Cincinnati College of Medicine. He interned at Baylor College of Medicine and completed his ophthalmology residency at the Cullen Eye Institute in Houston, acting as chief resident 1991-1992. He finished a two-year fellowship in vitreoretinal diseases and surgery at the University of Iowa, Iowa City, where he focused on disorders such as uveitis and genetic retinal diseases.

He is board certified by the American Board of Ophthalmology.

He is a member of the American Ophthalmology Association, American Medical Association, Escambia County Medical Association and the Florida Society of Ophthalmology.